Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo
Dr Pierre Fouret - Institut Gustave Roussy, France
Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo ( Dr Pierre Fouret - Institut Gustave Roussy, France )
3 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
Targeting death receptors in chemo-resistant cancer cells ( Prof Patrick Johnston - Queen's University Belfast, UK )
3 Jul 2009
ASCO: Pemetrexed extends survival as maintenance therapy
Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA
ASCO: Pemetrexed extends survival as maintenance therapy ( Dr. Chandra P. Belani - Penn State Cancer Institute, Hershey, Pennsylvania, USA )
18 Jun 2009
ASCO: Lung cancer screening by low-dose computed tomography results in high rate...
Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, US...
ASCO: Lung cancer screening by low-dose computed tomography results in high rate of false positives ( Dr. Jennifer M. Croswell - National Institutes of Health, Bethesda, Maryland, USA )
18 Jun 2009
ASCO: Maintenance therapy for NSCLC
Dr. Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, US...
ASCO: Maintenance therapy for NSCLC ( Dr.  Vincent A. Miller - MD Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2009
ASCO: Experimental targeted therapy improves progression-free survival for advan...
Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US
ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC ( Dr Roy Herbst, M.D. Anderson Cancer Center, Houston, US )
17 Jun 2009
Oestrogen and progestin therapy increases NSCLC risk
Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US
Oestrogen and progestin therapy increases NSCLC risk ( Dr Rowan Chlebowski - Harbor-UCLA Medical Center, Los Angeles, US )
17 Jun 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
AACR 2009: Genetics of pleuropulmonary blastoma
Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical C...
AACR 2009: Genetics of pleuropulmonary blastoma ( Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA )
1 May 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
Bacteria as agents to initiate potent anti-tumour activity ( Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan )
31 Mar 2009
COSMOS lung cancer study
Dr Giulia Veronesi - Deputy Director of the Division of Thoracic Surgery at the ...
COSMOS lung cancer study ( Dr Giulia Veronesi - Deputy Director of the Division of Thoracic Surgery at the European Institute of Oncology, Milan )
18 Mar 2009